Top compounds associated with response to CT45A9

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	cyanoquinoline 11	CTRPv2	pan-cancer	AAC	0.053	0.3
mRNA	ML162	CTRPv2	pan-cancer	AAC	0.035	0.3
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.037	0.3
mRNA	AZD8055	CTRPv2	pan-cancer	AAC	0.037	0.3
mRNA	selumetinib:PLX-4032 (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.037	0.3
mRNA	salermide	CTRPv2	pan-cancer	AAC	-0.048	0.3
mRNA	chlorambucil	CTRPv2	pan-cancer	AAC	-0.033	0.3
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.035	0.3
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.036	0.3
mRNA	CHIR-99021	CTRPv2	pan-cancer	AAC	-0.034	0.3

Download CSV